[0185] anticholinergic antagonists: hyoscyamine sul› fate; 

[0186] anticonvulsants: clorazepate dipotassium, lamotrigine, and lorazepam; 

[0187] antidiabetic agents: repaglinide, and rosiglita› zone maleate; 

[0188] anti-emetics: chlorpromazine HCl, dronab› inol, granisetron HCl, meclizine HCl, metoclopra› mide, ondansetron HCl, perphenazine, prochlorpera› zine, promethazine, and scopolamine; 

[0189] antihistamines: azelastine hydrochloride, ceti› rizine and cetirizine HCl, cyproheptadine HCl, dex› brompheniramine maleate, fexofenadine and fex› ofenadine HCl, loratadine, triprolidine, tripelenamine and diphenhydramine; 

[0190] antilipemic agents: HMG-CoA reductase inhibitors such as atorvastatine, fluvastatin, lovasta› tine, pravastatin and simvastatine; 

[0191] antimigraine preparations: dihydroergotamine mesylate, naratriptan, sumatriptan succinate, timolol, and zolmitriptan; 

[0192] antinauseants: granisetron and ondansetron; 

[0193] antipanic agents: alprazolam, clonazepam, paroxetine hydrochloride, sertraline, and sertraline HCl; 

[0194] antirheumatic agents: leflunomide, methotr› exate and NSAlDs; 

[0195] anti-ulcer agents: ameprazole, famotidine, lansoprazole and omerprazole; 

[0196] antiviral agents: acyclovir, penciclovir, riman› tadine hydrochloride, zanamivir, as well as nucleo› side analogues such as stavudine and zalcitabine; 

[0197] appetite stimulant: dronabinol; 

[0198] appetite suppressants: sibutramine, phenyl› propanolamine and obesity management drugs such as methamphetamine (e.g., methamphetamine hydrochloride), phendimetrazine tartrate, phenter› mine (e.g., phentermine hydrochloride), and sibutra› mine ( e.g., sibutramine hydrochloride monohy› drate ); 

[0199] antitussive agents: dextromethorphan hydro› bromide; 

[0200] benign prostatic hyperplasia agents: dox› azosin ( e.g., doxazosin mesylate ), finasteride, tam› sulosin, terazosin ( e.g., terazosin HCl); 

[0201] cardiovascular preparations: angiotensin con› verting enzyme inhibitors such as 3-(5-amino-l› carboxy-l S-pentyl)amino-2,3,4,5-tetrahydro-2- oxo-3 S-lH-1-benzazepine-l-acetic acid, l-carboxymethyl-3-l-carboxy-3-phenyl-(lS)-propy› lamino-2,3,4,5-tetrahydro-lH-(3S)-1-benzazepine- 2-one, enalapril, 3-(1-ethoxycarbonyl-3-phenyl-(IS)› propy lamina )-2,3,4,5-tetrahydro-2-oxo-(3S)› benzazepine-l -acetic acid monohydrochloride and lisinorpril; angiotensin III receptor antagonists such as candesartan, cilexetil, losartan potassium, valsar- 

tan, and telmisartan; anti-arrhythmics such as amio› darone, bretylium, disopyramide, digoxin, dofetilide, encainide, flecainide, ibutilide and ibutilide fuma› rate, lidocaine, mexiletine, moricizine, phenytoin, procainamide, quinidine, and tocainide; antiplatelet drugs such as anagrelide HCl, clopidogrel bisulfate, epoprostenol sodium, tirofiban HCl; beta-blockers such as acebutolol, atenolol, esmolol, metoprolol, pindolol, propafenone, propranolol, and sotalol; car› diac glycosides such as digoxin and digitoxin; car› dioprotective agents such as dexrazoxane and leu› covorin; vasodilators such as nitroglycerin; cholinergic agents such as arecoline; diuretics; pre› and afterload reducers; inotropes such as amrinone and milrinone; calcium channel blockers such as verapamil, nifedipine, nicardipene, felodipine, isra› dipine, nimodipine, bepridil, amlodipine and dilt› iazem; 

[0202] central nervous system agents: bromocriptine, –trans- l,3,4,4a,5,10~-hexahydro-4-propyl-2H-1- benzopyrano-3,4-bipyridine-9-ol monohydrochlo› ride, zolpidem tartrate; 

[0203] central nervous system stimulants: amphet› amine, dextroamphetamine, doxapram HCl, meth› amphetamine HCl, methylphenidate HCl, pemoline, phendimetrazine tartrate, phentermine HCl, and sibutramine HCl monohydrate; 

[0204] depigmenting agents: hydroquinone and monobenzone; 

[0205] erectile dysfunction therapies: alprostadil and sildenafil ( e.g., sildenafil citrate); 

[0206] gastrointestinal agents: antispasmodics such as glycopyrolate; histamine receptor antagonists such as famotidine; and proton pump inhibitors such as esomeprazole, lansoprazole, omeprazole, panto› prazole, and rabeprazole sodium; 

[0207] hematinic agents: cyanocobalamin (Vitamin B$_{12}$ ), ferric gluconate, ferric sulfate, ferrous glucon› ate, ferrous sulfate, and folic acid; 

[0208] hemostatic drugs: desmopressin and desmo› pressin acetate; 

[0209] hypocalcemics: calcitriol; 

[0210] immunosuppressive agents: tacrolimus and sirolimus; 

[0211] leukotriene inhibitors: montelukast sodium; 

[0212] motion sickness drugs: promethazine HCl and scopolamine; 

[0213] muscle relaxants: baclofen, cyclobenzaprine and cyclobenzaprine HCl, dantrolene, ritodrine HCl, tizanidine HCl, and tolterodine tartrate; 

[0214] nicotine; 

[0215] narcotic antagonists: naloxone, particularly naloxone hydrochloride; nutritional agents, includ› ing vitamins, minerals, essential amino acids and fatty acids, such as chromium picolinate, cyanoco› balamin (vitamin B$_{12}$ ), ferric glyconate, ferric sul› fate, ferrous glyconate, ferrous salt, ferrous sulfate, folic acid, vitamin C, zinc acetate, and zinc sulfate; 

